Loading insider details...
Beta
Latest Form 4 (Jun 12, 2026): Grant/Award of 5,000 XLO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 12, 2026 | Xilio Therapeutics, Inc. (XLO) | Grant/Award | 5,000 | n/a |
| Jun 5, 2026 | INSMED Inc (INSM) | Sale | 2,404 | $245.9K |
| May 15, 2026 | INSMED Inc (INSM) | Sale | 8,272 | $961.0K |
| Feb 4, 2026 | INSMED Inc (INSM) | Sale | 748 | $116.9K |
| Jan 8, 2026 | INSMED Inc (INSM) | Sale | 1,517 | $262.9K |
| Jan 6, 2026 | INSMED Inc (INSM) | Grant/Award | 5,998 | n/a |
| Oct 7, 2025 | scPharmaceuticals Inc. (SCPH) | Disposition to Issuer | 30,000 | n/a |
| Jul 23, 2025 | INSMED Inc (INSM) | Exercise/Conversion | 3,443 | $91.1K |
| Jul 9, 2025 | INSMED Inc (INSM) | Exercise/Conversion | 6,244 | $123.3K |
| Jun 25, 2025 | INSMED Inc (INSM) | Exercise/Conversion | 35,253 | $668.0K |